Rare diseases
Investigational molecules
Locations
265 Franklin Street Suite 1702, 02110-3144, United States
Imbria Pharmaceuticals Inc. focuses on non-obstructive hypertrophic cardiomyopathy, with particular attention to patients living with symptomatic disease and impaired health status.
The sponsor’s clinical activity is centered on cardiac conditions that affect daily functioning and quality of life.
Imbria Pharmaceuticals Inc. runs clinical trials in conditions such as Hypertrophic cardiomyopathy, Cardiomyopathy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
